| Code | 5641C | ||||||||||
| MA number | 49/0319/17-S | ||||||||||
| Product Form: | cps dur 20(1x20)x2 mg (blis.PVC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | BELUPO, s.r.o., Slovakia | ||||||||||
| Therapeutic Class: | 49 - DIGESTIVA, ADSORBENTIA, ACIDA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product not subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 30.10.2017 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric contraindication: | Yes |
| PIL: |
PIL_BELOPERA 2 mg_cps dur_04_2023.pdf
|
| SPC: |
SPC_BELOPERA 2 mg_cps dur_04_2023.pdf
|
| Safety feature | No |
| Data update: | 17.05.2023 |
